Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity

Annali dell'Istituto Superiore di Sanita

Volumn 40, Issue 1, 2004, Pages 81-88

  Lappalainen, Maija ^a   Hedman, Klaus ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Congenital toxoplasmosis; Diagnosis; Enzyme immunoassay; IgG avidity; Ocular toxoplasmosis; Serodiagnostic assay; Toxoplasma; Toxoplasmosis during pregnancy

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ASSAY; CHILD; CONGENITAL TOXOPLASMOSIS; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; IMMUNE DEFICIENCY; LABORATORY TEST; MEASUREMENT; NEWBORN; POLYMERASE CHAIN REACTION; PREGNANCY; PRIMARY INFECTION; REVIEW; SERODIAGNOSIS; TOXOPLASMOSIS;

ACUTE DISEASE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY AFFINITY; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEROLOGIC TESTS; TOXOPLASMA; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL; TOXOPLASMOSIS, OCULAR;

EID: 4744365347     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO (Ed.). Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: W.B. Saunders; 1995. p. 140-267.
2. Pinon JM, Thoannes H, Gruson N. An enzyme-linked immunofiltration assay used to compare infant and maternal antibody profiles in toxoplasmosis. J Immunol Methods 1985;77:15-23.
3. Sulzer A, Franco EL, Takafuji E, Benenson M, Walls KW, Greenup RL. An oocyst-transmitted outbreak of toxoplasmosis. Patterns of immunoglobulin G and M over one year. Am J Trop Med Hyg 1986;35:290-6.
4. Brooks RG, McCabe RE, Remington JS. Role of serology in the diagnosis of toxoplasmic lymphadenopathy. Rev Infect Dis 1987;9:1055-62.
5. Herbrink P, van Loon AM, Rotmans JP. van Knapen F, van Dijk WC. Interlaboratory evaluation of indirect enzyme-linked immunosorbent assay, antibody capture enzyme-linked immunosorbent assay, and immunoblotting for detection of immunoglobulin M antibodies to Toxoplasma gondii. J Clin Microbiol 1987;25:100-5.
6. Del Bono V, Canessa A, Bruzzi P, Fiorelli MA, Terragna A. Significance of specific immunoglobulin M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy. J Clin Microbiol 1989;27:2133-5.
7. Hedman K, Lappalainen M, Seppälä I, Mäkelä O. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 1989;159:736-40.
8. Hedman K, Lappalainen M, Söderlund M, Hedman L. Avidity of IgG in serodiagnosis of infectious diseases. Rev Med Microbiol 1993;4:123-9.
9. Werblin TP, Siskind GW. Distribution of antibody affinities: technique of measurement. Immunochemistry 1972;9:987-1011.
10. Kim YT, Werblin TP, Siskind GW. Distribution of antibody-binding affinity. III. Detection of low affinity antibody in the presence of high affinity antibody. J Immunol 1974;112:2002-12.
11. Inouye S, Hasegawa A, Matsuno S, Katow S. Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J Clin Microbiol 1984;20:525-9.
12. Devey ME, Bleasdale K, Lee S, Rath S. Determination of the functional affinity of IgG1 and IgG4 antibodies to tetanus toxoid by isotype-specific solid-phase assays. J Immunol Methods 1988;106:119-25.
13. Thomas HIJ, Morgan-Capner P. The use of antibody avidity measurements for the diagnosis of rubella. Rev Med Virol 1991;1:41-50.
14. Pullen GR, Fitzgerald MG, Hosking CS. Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods 1986;86:83-7.
15. Hedman K, Seppälä I. Recent rubella virus infection indicated by a low avidity of specific IgG. J Clin Immunol 1988;8:214-21.
16. Blackburn NK, Besselaar TG, Schoub BD, O'Connell KF. Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity. J Med Virol 1991;33:6-9.
17. Hedman K, Vaheri A, Brummer-Korvenkontio M. Rapid diagnosis of hantavirus disease with an IgG-avidity assay. Lancet 1991;338:1353-6.
18. Ward KN, Gray JJ, Fotheringham MW, Sheldon MJ. IgG antibodies to human herpesvirus-6 in young children. Changes in avidity of antibody correlate with time after infection. J Med Virol 1993;39:131-8.
19. Ward KN, Dhaliwal W, Ashworth KL, Clutterbuck EJ, Teo CG. Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody. J Med Virol 1994;43:367-72.
20. Lutz E, Ward KN, Gray JJ. Maturation of antibody avidity after primary human cytomegalovirus infection is delayed in immunosuppressed solid organ transplant patients. J Med Virol 1994;44:317-22.
21. Söderlund M, Brown CS, Cohen BJ, Hedman K. Accurate serodiagnosis of B 19 parvovirus infections by measurement of IgG avidity. J Infect Dis 1995;171:710-3.
22. Prince HE, Wilson M. Simplified assay for measuring Toxoplasma gondii immunoglobulin G avidity. Clin Diagn Lab Immunol 2001;8:904-8.
23. Lecolier B, Pucheu B. Interét de l'etude de l'avidité des IgG pour le diagnostic de la toxoplasmose. Pathol Biol 1993;41:155-8.
24. Korhonen MH, Brunstein J, Haario H, Katnikov A, Rescaldani R, Hedman K. A new method with general diagnostic utility for the calculation of immunoglobulin G avidity. Clin Diagn Lab Immunol 1999;6:725-8.
25. Gutiérrez J, Rodríguez M, Piédrola G, Maroto MC. Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis. Clin Microbiol Infect 1997;3:658.
26. Pelloux H, Brun E, Vernet G, Marcillat S, Jolivet M, Guergour D, Fricker-Hidalgo H, Goullier-Fleuret A, Ambroise-Thomas P. Determination of anti-Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (bioMerieux). Diagn Microbiol Infect Dis 1998;32:69-73.
27. Barberi A, Gistri A, Cappelletti F, Giordano I. Diagnostic value of IgG avidity in Toxoplasma infection: comparison of 3 commercial kits. J Infect Dis 2001;184:944.
28. Liesenfeld O, Montoya JG, Remington JS. Reply. J Infect Dis 2001;184:944-5.
29. Marcolino PT, Silva DAO, Leser PG, Camargo ME, Mineo JR. Molecular markers in acute and chronic phases of human toxoplasmosis: determination of immunoglobulin G avidity by western blotting. Clin Diagn Lab Immunol 2000;7:384-9.
30. Gard S, Magnusson JH. A glandular form of toxoplasmosis in connection with pregnancy. Acta Med Scand 1951;161:59-64.
31. McCabe RE, Brooks RG, Dorfman RF, Remington JS. Clinical spectrum in 107 cases of toxoplasmic lymphadenopathy. Rev Infect Dis 1987;9:754-74.
32. de Ory F, Casas I, Domingo CJ, Echevarria JM. Application of fluoroimmunoassay to the identification of low avidity specific IgG against pathogenic human viruses and Toxoplasma gondii. Clin Diagn Virol 1995;3:323-32.
33. Sensini A, Pascoli S, Marchetti D, Castronari R, Marangi M, Sbaraglia G, Cimmino C, Favero A, Castelletto M, Mottola A. IgG avidity in the serodiagnosis of acute Toxoplasma gondii infection: a multicenter study. Clin Microbiol Infect 1996;2:25-9.
34. Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS. Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis 2001;183:1248-53.
35. Cozon GJN, Ferrandiz J, Nebhi H, Wallon M, Peyron F. Estimation of the avidity of immunoglobulin G for routine diagnosis of chronic Toxoplasma gondii infection in pregnant women. Eur J Clin Microbiol Infect Dis 1998;17:32-6.
36. van Druten H, van Knapen F, Reintjes A. Epidemiologic implications of limited-duration seropositivity after toxoplasma infection. Am J Epidemiol 1990;132:169-80.
37. Lutz E, Ward KN, Gray JJ. Maturation of antibody avidity after primary human cytomegalovirus infection is delayed in immunosuppressed solid organ transplant patients. J Med Virol 1994;44:317-22.
38. Ashburn D, Joss AWL, Pennington TH, Ho-Yen DO. Do IgA, IgE and IgG avidity tests have any value in the diagnosis of toxoplasma infection in pregnancy? J Clin Pathol 1998;51:312-5.
39. Lappalainen M, Koskela P, Koskiniemi M, Ämmälä P, Hiilesmaa V, Teramo K, Raivio KO, Remington JS, Hedman K. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of immunoglobulin G. J Infect Dis 1993;167:691-7.
40. Desmonts G, Couvreur J. Congenital toxoplasmosis. A prospective study of the offspring of 542 women who acquired toxoplasmosis during pregnancy. Pathophysiology of congenital disease. In: Thalhammer O, Baumgarten K, Pollak A (Ed.). Pathophysiology of congenital disease. Perinatal medicine. 6th European Congress of Vienna, 1978. Stuttgart: Georg Thieme Verlag; 1979. p. 51-60.
41. Roberts A, Hedman K, Luyasu V, Zufferey J, Bessières, J-H, Blatz, R-M, Candolfi E, Decoster A, Enders G, Gross U, Guy E, Hayde M, Ho-Yen D, Johnson J, Lécolier B, Naessens A, Pelloux H, Thulliez P, Petersen E. Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis 2001;20:467-74.
42. Jenum PA, Stray-Pedersen B, Gundersen AG. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol 1997;35:1972-7.
43. Holliman RE, Raymond R, Renton N, Johnson JD. The diagnosis of toxoplasmosis using IgG avidity. Epidemiol Infect 1994;112:399-408.
44. Joynson DHM, Payne RA, Rawal BK. Potential role of IgG avidity for diagnosing toxoplasmosis. J Clin Pathol 1990;43:1032-3.
45. Hohlfeld P, Daffos F, Costa J-M, Thulliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med 1994;331:695-9.
46. Jenum PA, Holberg-Petersen M, Melby KK, Stray-Pedersen B. Diagnosis of congenital Toxoplasma gondii infection by polymerase chain reaction (PCR) on amniotic fluid samples. APMIS 1998;106:680-6.
47. Ho-Yen DO, Joss AWL (Ed.). Human Toxoplasmosis. Oxford: Oxford University Press; 1992. p. 265.
48. Koppe JG, Loewer-Sieger DH, de Roever-Bonnet H. Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1986;i:254-6.
49. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital toxoplasma infection. Pediatrics 1980;66:767-74.
50. Sever JL, Ellenberg JH, Ley AC, Madden DL, Fuccillo DA, Tzan NR, Edmonds DM. Toxoplasmosis: maternal and pediatric findings in 23 000 pregnancies. Pediatrics 1988;82:181-92.
51. Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Aufrant C, Valenti D, Cox WL. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 1988;318:271-5.
52. Desmonts G, Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Chartier M. Prenatal diagnosis of congenital toxoplasmosis. Lancet 1985;i:500-4.
53. Naessens A, Jenum PA, Pollak A, Decoster A, Lappalainen M, Villena I, Lebech M, Stray-Pedersen B, Hayde M, Pinon J-M, Petersen E, Foulon W. Diagnosis of congenital toxoplasmosis in the neonatal period: A multicenter evaluation. J Pediatr 1999;135:714-9.
54. Lappalainen M, Koskiniemi M, Hiilesmaa V, Ämmälä P, Teramo K, Koskela P, Lebech M, Raivio KO, Hedman K, and the Study Group. Outcome of children after maternal primary toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. Pediatr Infect Dis J 1995;14:354-61.
55. Thomas HIJ, Morgan-Capner P. Enders G, O'Shea S, Caldicott D, Best JM. Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods 1992;39(1-2):149-55.
56. Herne V, Hedman K, Reedik P. Immunoglobulin G avidity in serodiagnosis of congenital rubella syndrome. Eur J Clin Microbiol Infect Dis 1997;16:763-6.
57. Fitzgerald MG, Pullen GR, Hosking CS. Low affinity antibody to rubella antigen in patients after rubella infection in utero. Pediatrics 1988;81:812-4.
58. de Jong PTVM. Ocular toxoplasmosis; common and rare symptoms and signs. Int Ophthalmol 1989;13:391-7.
59. Friedman CT, Knox DL. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 1969;81:481-493.
60. Crawford JB. Toxoplasma retinochoroiditis. Arch Ophthalmol 1966;76:829-832.
61. Perkins ES. Ocular toxoplasmosis. Br J Ophthalmol 1973;57:1-17.
62. Masur H, Jones TC, Lempert JA, Cherubini TD. Outbreak of toxoplasmosis in a family and documentation of acquired retinochoroiditis. Am J Med 1978;64:396-402.
63. Silveira C, Belfort JR, Burnier JM, Nussenblatt R. Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. Am J Ophthalmol 1988;106:362-4.
64. Glasner PD, Silveira C, Kruszon-Moran D, Martins MC, Burnier Jr M, Silveira S, Camargo ME, Nussenblatt RB, kaslow RA, Belfort Jr R. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol 1992;114:136-44.
65. Pedersen OO, Lorentzen-Styr A-M. Antibodies against Toxoplasma gondii in the aqueous humour of patients with active retinochoroiditis. Acta Ophthalmol 1981;59:719-26.
66. Turunen HJ, Leinikki PO, Saari M. Demonstration of intraocular synthesis of immunoglobulin G toxoplasma antibodies for specific diagnosis of toxoplasmic chorioretinitis by enzyme immunoassay. J Clin Microbiol 1983;17:988-92.
67. Garweg JG, Jacquier P, Boehnke M. Early aqueous humor analysis in patients with human ocular toxoplasmosis. J Clin Microbiol 2000;38:996-1001.
68. Rothova A, van Knapen F, Baarsman GS, Kruit PJ, Loewer-Sieger DH, Kijlstra A. Serology in ocular toxoplasmosis. Br J Ophthalmol 1986;70:615-22.
69. Kijlstra A, Luyendijk L, Baarsma GS, Rothova A, Schweitzer CMC, Timmerman Z, de Vries J, Breebaart AC. Aqueous humor analysis as a diagnostic tool in toxoplasma uveitis. Int Ophthalmol 1989;13:383-6.
70. Holliman RE, Stevens PJ, Duffy KT, Johnson JD. Serological investigation of ocular toxoplasmosis. Br J Ophthalmol 1991;75:353-5.
71. Paul M. Immunoglobulin G avidity in diagnosis of toxoplasmic lymphadenopathy and ocular toxoplasmosis. Clin Diagn Lab Immunol 1999;6:514-8.
72. Vietzke WM, Gelderman AH, Grimley PM, Valsamis MP. Toxoplasmosis complicating malignancy. Cancer 1968;21:816-27.
73. Luft BJ, Naot Y, Araujo FG, Stinson EB, Remington JS. Primary and reactivated toxoplasma infection in patients with cardiac transplants. Ann Int Med 1983;99:27-31.
74. Michaels MG, Wald ER, Fricker FJ, del Nido PJ, Armitage J. Toxoplasmosis in pediatric recipients of heart transplants. Clin Infect Dis 1992;14:847-51.
75. Pomeroy C, Filice GA. Pulmonary toxoplasmosis: a review. Clin Infect Dis 1992;14:863-70.
76. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992;327:1643-8.
77. Luft BJ, Hafner R, Korzun AH, Leport C, Antoniskis D, Bosler EM, Bourland III DD, Uttamchandani R, Fuhrer J, Jacobson J, Morlat P, Vilde JL, Remington JS, Members of the ACTG 077p/ANRS 009 Study Team. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1993;329:995-1000.
78. Holliman RE. Toxoplasmosis and the acquired immune deficiency syndrome. J Infect 1988;16:121-8.
79. Angel S, Maero E, Blanco JC, Pzsenny V, Zala C, Gonzales R, Perelmulter H, Garberi JC. Early diagnosis of toxoplasmic encephalitis in AIDS patients by dot blot hybridization analysis. J Clin Microbiol 1992;30:3286-7.
80. Lappalainen M, Jokiranta TS, Halme L, Tynninen O, Lautenschlager I, Hedman K, Höckerstedt K, Meri S. Disseminated toxoplasmosis after liver transplantation: case report and review. Clin Infect Dis 1998;27:1327-8.